{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:26:12Z","timestamp":1787775972143,"version":"build-2784847793"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The coronavirus disease 2019 (COVID-19) pandemic has led to a global health crisis, with mass vaccination being a pivotal strategy in mitigating its impact. However, adverse events following immunization\/vaccination have raised concerns, although most are mild. This case report details a 33-year-old male who developed fatal acute respiratory distress syndrome, congestive cardiac failure, and multi-organ failure after receiving the second dose of the COVID-19 vaccine. Autopsy revealed underlying mitral stenosis complicated by infective endocarditis, which likely contributed to the patient\u2019s death. Cytological, biochemical, and microbiological examinations of pleural, pericardial, and peritoneal fluids were inconclusive in identifying a specific cause. The temporal association between vaccination and death warrants further investigation, although definitive evidence linking the vaccine to the adverse event remains unclear. The findings emphasize the importance of continuous monitoring and further research into vaccine safety, whereas reinforcing the critical role of mass vaccination in controlling the pandemic.<\/jats:p>","DOI":"10.4103\/aam.aam_106_25","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:00:08Z","timestamp":1751018408000},"page":"480-483","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Are Coronavirus Disease 2019 Vaccinations Causing Fatal Adverse Event? A Comprehensive Case Discussion Based on WHO Adverse Events Following Immunization Causality Criteria"],"prefix":"10.4103","volume":"25","author":[{"given":"Debasree","family":"Debnath","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, Agartala Government Medical College and G.B.P. Hospital, Agartala, Tripura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utpal","family":"Tripura","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences, Kalyani, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthika","family":"Debbarma","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, Agartala Government Medical College and G.B.P. Hospital, Agartala, Tripura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"1-2","key":"R6-20260311","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cccn.2004.02.002","article-title":"Biochemical analysis of pleural, peritoneal and pericardial effusions","volume":"343","author":"Burgess","year":"2004","journal-title":"Clinica Chimica Acta"},{"key":"R8-20260311","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.3390\/jcm13237291","article-title":"The WHO algorithm for causality assessment of adverse effects following immunization with genetic-based anti-COVID-19 vaccines:Pitfalls and suggestions for improvement","volume":"13","author":"Bellavite","year":"2024","journal-title":"J Clin Med"},{"key":"R9-20260311","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cyto.a.24662","article-title":"Mass versus personalized medicine against COVID-19 in the \u201csystem sciences\u201dera","volume":"101","author":"Teodori","year":"2022","journal-title":"Cytometry A"},{"key":"R10-20260311","doi-asserted-by":"crossref","first-page":"e200721194929","DOI":"10.2174\/1871526521666210720124950","article-title":"Genetics and vaccine development for SARS-CoV2 in the era of personalized medicine","volume":"22","author":"Tafanidou","year":"2022","journal-title":"Infect Disord Drug Targets"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_106_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:47:06Z","timestamp":1787773626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_106_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_106_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"2025-04-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}